Skip to main content
. 2018 Jul 9;4(4):238–249. doi: 10.1192/bjo.2018.32

Table 1.

Characteristics of the included systematic reviews

First author, year Inclusion criteria Outcomes Assessment of dementia Databases searched and search window Articles included in review, articles included in meta-analysis Number of patients Design of the included articles Main conclusion
Annweiler, 200911 Data on serum 25(OH)D and cognitive status or diagnosed dementia, only studies with a healthy control group and use of a regression model for analysis in French and English Cognitive status or diagnosed dementia Not defined MEDLINE, Cochrane library, PsychINFO between 1979 and December 2008 5 studies, N/A 19 597 Cross-sectional (n = 4),
case–control (n = 1)
Inconclusive results on the association between serum 25(OH)D and cognitive performance
Annweiler, 201314 Any type of observational/ interventional studies, data on serum 25(OH)D and Alzheimer disease, adult humans, written in Latin alphabet Alzheimer disease Not defined MEDLINE, PsychINFO from inception to May 2012 10 studies,
7 studies
1005 Case–control (n = 7),
nested case–control (n = 2), prospective (n = 1)
Patients with Alzheimer disease had lower serum 25(OH)D compared with matched controls
Annweiler, 201315 Any type of observational/ interventional study, data on 25(OH)D and cognition, adult humans, written in Latin alphabet Memory and executive dysfunction N/A MEDLINE, PsychINFO from inception to May 2012 17 studies,
12 studies
39 975 Cross-sectional (n = 11),
prospective (n = 3), pre-post design (n = 2), RCT (n = 1)
Lower serum 25(OH)D concentration predicts executive dysfunction (mental shifting, information updating, processing speed), uncertain association with episodic memory
Balion, 201212 Any type of observational/interventional studies, data on 25(OH)D, cognition and dementia, humans aged >18 years, written in English Cognitive function, dementia NINCDS–ADRDA, DSM-III or IV, MMSE MEDLINE, Embase, AMED, Cochrane library, PsychINFO from inception to August 2010 37 studies,
4 studies (Alzheimer disease),
10 studies (MMSE test)
≅35 000 Cross-sectional (n = 21, case–control (n = 10),
prospective (n = 2), pre-post design (n = 1), RCT (n = 3)
Lower 25(OH)D concentrations are associated with poorer cognitive function and a higher risk of Alzheimer disease
Cao, 201619 Cohort studies including white patients, with follow-up for 1 year, data presented as risk or hazard ratios, with 95% CIs or with enough data to calculate these numbers, data on any type of dietary pattern or food consumption and dementia or mild cognitive impairment, on humans, and written in English Dementia or mild cognitive impairment Diagnostic codes MEDLINE, Embase, BIOSIS, Cochrane library from 1997 to September 2014 3 studies,
3 studies
12 702 Prospective cohort (n = 3) Low levels of vitamin D related to increase in dementia
Etgen, 201213 Cross-sectional or longitudinal studies, at least 100 participants, data on vitamin D and cognitive impairment, results presented as odds or hazard ratios Cognitive impairment N/A MEDLINE, Cochrane library, from 1980 to April 2012 15 studies,
7 studies
7688 in meta-analysis Cross-sectional (n = 9),
prospective (n = 2)
An increased risk of cognitive impairment in those with low vitamin D
Lopes da Silva, 20147 Data on any type of plasma nutrient status and Alzheimer disease Alzheimer disease NINCDS–ADRDA, DSM III or IV MEDLINE, Embase, Cochrane library, from 1990 to March 2012 5 studies,
5 studies
865 Case–control
(n = 5)
No association between low levels of vitamin D and Alzheimer disease
Shen, 201518 Data on 25(OH)D concentration with cut-off point of <50 nmol/L and Alzheimer disease or dementia, results presented as odds, risk, or hazard ratios, written in English Alzheimer disease and dementia Not defined MEDLINE, from inception to February 2015 Alzheimer disease:
5 studies,
5 studies
Dementia:
5 studies,
4 studies
Alzheimer disease: 10 019
Dementia: 5073
Alzheimer disease:
cross-sectional (n = 1),
prospective (n = 4)
Dementia:
cross-sectional (n = 3),
prospective (n = 2)
Lower vitamin D status is associated with increased risk of developing Alzheimer disease and dementia
Sommer, 201720 RCTs, prospective cohort and nested case–control, systematic reviews of longitudinal studies with data on the effect of sunlight exposure or vitamin D serum concentrations (as surrogate) and dementia, among adults, written in English and German Dementia: Alzheimer disease vascular, frontotemporal,
Lewy body
Based on validated measurement scales MEDLINE, Embase, Cochrane library, SCOPUS, Web of Science, ICONDA, PsychINFO, the Open Grey database, from 1990 to October 2015 6 studies,
5 studies
18 933 Prospective (n = 5), retrospective (n = 1) Vitamin D deficiency increases the risk of dementia
van der Schaft,
201316
Observational studies with data on vitamin D (serum concentration or dietary intake) and cognition in adult humans, available measure of association Cognition Cognitive function test (e.g. MMSE, CDT) Embase, PubMed from inception to June 2012 28 studies,
N/A
59 576 Cross-sectional (n = 25),
prospective (n = 6)
Hypovitaminosis D is associated with worse outcome on one or more cognitive function tests and a higher frequency of dementia
Zhao, 201317 Comparative analysis of 25(OH)D of individuals with Alzheimer disease against healthy population Alzheimer disease Not defined MEDLINE, from 1983 to March 2012 6 studies,
6 studies
892 Case–control
(n = 6)
Patients with Alzheimer disease had non-significant lower levels of 25(OH)D relative to healthy controls

25(OH)D, 25-hydroxyvitamin D; AMED, Allied and Complimentary Medicine Database; BIOSIS, BioSciences Information Service of Biological Abstracts; CDT, Wolf–Klein Clock Drawing Test; ICONDA, International Construction Database; MMSE, Mini-Mental State Examination; N/A, not applicable; NINCDS–ADRDA, National Institute Neurological and Communicative Disorders and Stroke–Alzheimer Disease and Related Disorders Association; RCT, randomised controlled trial; SCOPUS, Elsevier abstract and citation database.